Trichostatin A-treated eight-cell bovine embryos had increased histone acetylation and gene expression, with increased cell numbers at the blastocyst stage

Shogo Shiratsuki, Hisataka Iwata, Koji Kimura, Takeshi Kuge, Yasunori Monji, Takehito Kuwayama

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The objective was to determine the effects of trichostatin A (TSA), a potent histone deacetylase inhibitor, on eight-cell bovine embryos. That treatment increased histone acetylation was confirmed by immunostaining with anti-AcH4K5 and AcH4K8 antibodies. Embryos treated with TSA (100 nM) for various intervals (4, 8, and 12 h) developed to the blastocyst stage as frequently as untreated embryos (average development rate, 49.5%). Treatment with TSA for 12 h increased (P <0.05) the numbers of inner cell mass (ICM) cells and total cells (TC), as well as the ICM/TC ratio in the blastocyst, but the number of cells in the trophectoderm decreased (P <0.05). Treated embryos had increased relative abundance (RA) of OCT3/4 and E-CADHERIN mRNA relative to controls at the morula stage (P <0.05), however, the RA of CDX2 mRNA was unchanged. In conclusion, TSA-treated eight-cell stage embryos had increased histone acetylation and gene expression, which increased ICM and TC numbers and the ICM/TC ratio, but significantly decreased the number of cells in the trophectoderm of resulting blastocysts.

Original languageEnglish
Pages (from-to)841-848
Number of pages8
JournalTheriogenology
Volume75
Issue number5
DOIs
Publication statusPublished - Mar 15 2011
Externally publishedYes

Fingerprint

trichostatin A
acetylation
Blastocyst
Acetylation
histones
blastocyst
Histones
embryo (animal)
Embryonic Structures
Cell Count
Gene Expression
gene expression
cattle
cells
Morula
Messenger RNA
Histone Deacetylase Inhibitors
Embryonic Development
histone deacetylase
morula

Keywords

  • Blastocyst
  • Bovine embryo development
  • Gene expression
  • Trichostatin A

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Equine
  • Food Animals
  • Small Animals

Cite this

Trichostatin A-treated eight-cell bovine embryos had increased histone acetylation and gene expression, with increased cell numbers at the blastocyst stage. / Shiratsuki, Shogo; Iwata, Hisataka; Kimura, Koji; Kuge, Takeshi; Monji, Yasunori; Kuwayama, Takehito.

In: Theriogenology, Vol. 75, No. 5, 15.03.2011, p. 841-848.

Research output: Contribution to journalArticle

Shiratsuki, Shogo ; Iwata, Hisataka ; Kimura, Koji ; Kuge, Takeshi ; Monji, Yasunori ; Kuwayama, Takehito. / Trichostatin A-treated eight-cell bovine embryos had increased histone acetylation and gene expression, with increased cell numbers at the blastocyst stage. In: Theriogenology. 2011 ; Vol. 75, No. 5. pp. 841-848.
@article{286b4b16a48247e5a2a1c1174eb19b59,
title = "Trichostatin A-treated eight-cell bovine embryos had increased histone acetylation and gene expression, with increased cell numbers at the blastocyst stage",
abstract = "The objective was to determine the effects of trichostatin A (TSA), a potent histone deacetylase inhibitor, on eight-cell bovine embryos. That treatment increased histone acetylation was confirmed by immunostaining with anti-AcH4K5 and AcH4K8 antibodies. Embryos treated with TSA (100 nM) for various intervals (4, 8, and 12 h) developed to the blastocyst stage as frequently as untreated embryos (average development rate, 49.5{\%}). Treatment with TSA for 12 h increased (P <0.05) the numbers of inner cell mass (ICM) cells and total cells (TC), as well as the ICM/TC ratio in the blastocyst, but the number of cells in the trophectoderm decreased (P <0.05). Treated embryos had increased relative abundance (RA) of OCT3/4 and E-CADHERIN mRNA relative to controls at the morula stage (P <0.05), however, the RA of CDX2 mRNA was unchanged. In conclusion, TSA-treated eight-cell stage embryos had increased histone acetylation and gene expression, which increased ICM and TC numbers and the ICM/TC ratio, but significantly decreased the number of cells in the trophectoderm of resulting blastocysts.",
keywords = "Blastocyst, Bovine embryo development, Gene expression, Trichostatin A",
author = "Shogo Shiratsuki and Hisataka Iwata and Koji Kimura and Takeshi Kuge and Yasunori Monji and Takehito Kuwayama",
year = "2011",
month = "3",
day = "15",
doi = "10.1016/j.theriogenology.2010.10.026",
language = "English",
volume = "75",
pages = "841--848",
journal = "Theriogenology",
issn = "0093-691X",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Trichostatin A-treated eight-cell bovine embryos had increased histone acetylation and gene expression, with increased cell numbers at the blastocyst stage

AU - Shiratsuki, Shogo

AU - Iwata, Hisataka

AU - Kimura, Koji

AU - Kuge, Takeshi

AU - Monji, Yasunori

AU - Kuwayama, Takehito

PY - 2011/3/15

Y1 - 2011/3/15

N2 - The objective was to determine the effects of trichostatin A (TSA), a potent histone deacetylase inhibitor, on eight-cell bovine embryos. That treatment increased histone acetylation was confirmed by immunostaining with anti-AcH4K5 and AcH4K8 antibodies. Embryos treated with TSA (100 nM) for various intervals (4, 8, and 12 h) developed to the blastocyst stage as frequently as untreated embryos (average development rate, 49.5%). Treatment with TSA for 12 h increased (P <0.05) the numbers of inner cell mass (ICM) cells and total cells (TC), as well as the ICM/TC ratio in the blastocyst, but the number of cells in the trophectoderm decreased (P <0.05). Treated embryos had increased relative abundance (RA) of OCT3/4 and E-CADHERIN mRNA relative to controls at the morula stage (P <0.05), however, the RA of CDX2 mRNA was unchanged. In conclusion, TSA-treated eight-cell stage embryos had increased histone acetylation and gene expression, which increased ICM and TC numbers and the ICM/TC ratio, but significantly decreased the number of cells in the trophectoderm of resulting blastocysts.

AB - The objective was to determine the effects of trichostatin A (TSA), a potent histone deacetylase inhibitor, on eight-cell bovine embryos. That treatment increased histone acetylation was confirmed by immunostaining with anti-AcH4K5 and AcH4K8 antibodies. Embryos treated with TSA (100 nM) for various intervals (4, 8, and 12 h) developed to the blastocyst stage as frequently as untreated embryos (average development rate, 49.5%). Treatment with TSA for 12 h increased (P <0.05) the numbers of inner cell mass (ICM) cells and total cells (TC), as well as the ICM/TC ratio in the blastocyst, but the number of cells in the trophectoderm decreased (P <0.05). Treated embryos had increased relative abundance (RA) of OCT3/4 and E-CADHERIN mRNA relative to controls at the morula stage (P <0.05), however, the RA of CDX2 mRNA was unchanged. In conclusion, TSA-treated eight-cell stage embryos had increased histone acetylation and gene expression, which increased ICM and TC numbers and the ICM/TC ratio, but significantly decreased the number of cells in the trophectoderm of resulting blastocysts.

KW - Blastocyst

KW - Bovine embryo development

KW - Gene expression

KW - Trichostatin A

UR - http://www.scopus.com/inward/record.url?scp=79951810101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951810101&partnerID=8YFLogxK

U2 - 10.1016/j.theriogenology.2010.10.026

DO - 10.1016/j.theriogenology.2010.10.026

M3 - Article

C2 - 21144563

AN - SCOPUS:79951810101

VL - 75

SP - 841

EP - 848

JO - Theriogenology

JF - Theriogenology

SN - 0093-691X

IS - 5

ER -